These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 28377550

  • 1. Drugs for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):57-62. PubMed ID: 28377550
    [No Abstract] [Full Text] [Related]

  • 2. Correct use of inhalers for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):e67-e71. PubMed ID: 28377554
    [No Abstract] [Full Text] [Related]

  • 3. Some inhaled corticosteroids for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):e66-e666. PubMed ID: 28377553
    [No Abstract] [Full Text] [Related]

  • 4. Inhaled short-acting bronchodilators for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):e62-e63. PubMed ID: 28377551
    [No Abstract] [Full Text] [Related]

  • 5. Inhaled long-acting bronchodilators for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):e64-e65. PubMed ID: 28377552
    [No Abstract] [Full Text] [Related]

  • 6. Trelegy Ellipta--a three-drug inhaler for COPD.
    Med Lett Drugs Ther; 2018 May 21; 60(1547):86-88. PubMed ID: 29913467
    [No Abstract] [Full Text] [Related]

  • 7. Changes in inhaler devices for asthma and COPD.
    Capriotti T.
    Medsurg Nurs; 2005 Jun 21; 14(3):185-94. PubMed ID: 16035636
    [No Abstract] [Full Text] [Related]

  • 8. Nebulized glycopyrrolate (Lonhala Magnair) for COPD.
    Med Lett Drugs Ther; 2018 Apr 23; 60(1543):72. PubMed ID: 29667949
    [No Abstract] [Full Text] [Related]

  • 9. Status of and strategies for improving adherence to COPD treatment.
    López-Campos JL, Quintana Gallego E, Carrasco Hernández L.
    Int J Chron Obstruct Pulmon Dis; 2019 Apr 23; 14():1503-1515. PubMed ID: 31371936
    [Abstract] [Full Text] [Related]

  • 10. Five questions in chronic obstructive pulmonary disease.
    Miravitlles M.
    Expert Rev Respir Med; 2013 Apr 23; 7(2 Suppl):1-2. PubMed ID: 23551018
    [No Abstract] [Full Text] [Related]

  • 11. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J, Dik N, Bugden S.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr 23; 11():3101-3108. PubMed ID: 27994449
    [Abstract] [Full Text] [Related]

  • 12. Is adherence to treatment influenced by the ability to use inhaled devices in patients with COPD correctly?
    Latorre M, Parri G, Paggiaro P.
    Pulmonology; 2020 Apr 23; 26(2):63-65. PubMed ID: 32033884
    [No Abstract] [Full Text] [Related]

  • 13. Emerging inhalers in the management of COPD.
    Ball J.
    S D Med; 2015 Apr 23; 68(4):169-71. PubMed ID: 25946896
    [No Abstract] [Full Text] [Related]

  • 14. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL, Calero Acuña C.
    Expert Rev Respir Med; 2013 Apr 23; 7(2 Suppl):43-51. PubMed ID: 23551023
    [Abstract] [Full Text] [Related]

  • 15. Seebri Neohaler and Utibron Neohaler for COPD.
    Med Lett Drugs Ther; 2016 Mar 28; 58(1491):39-41. PubMed ID: 27027687
    [No Abstract] [Full Text] [Related]

  • 16. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, Oh YM, Lee SD, Park YB.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 28; 11():2797-2803. PubMed ID: 27877033
    [Abstract] [Full Text] [Related]

  • 17. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T.
    MMW Fortschr Med; 2015 May 28; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract] [Full Text] [Related]

  • 18. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
    Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J.
    Int J Chron Obstruct Pulmon Dis; 2017 May 28; 12():1825-1836. PubMed ID: 28684905
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
    Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R.
    Int J Chron Obstruct Pulmon Dis; 2018 May 28; 13():781-792. PubMed ID: 29551894
    [Abstract] [Full Text] [Related]

  • 20. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
    Vogelmeier C, Worth H, Buhl R, Criée CP, Lossi NS, Mailänder C, Kardos P.
    Int J Chron Obstruct Pulmon Dis; 2017 May 28; 12():487-494. PubMed ID: 28203072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.